These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9119714)

  • 21. Judging the effectiveness of analgesia for children and adolescents during vaso-occlusive events of sickle cell disease.
    Beyer JE
    J Pain Symptom Manage; 2000 Jan; 19(1):63-72. PubMed ID: 10687328
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low-Dose Ketamine Infusion for Adjunct Management during Vaso-occlusive Episodes in Adults with Sickle Cell Disease: A Case Series.
    Palm N; Floroff C; Hassig TB; Boylan A; Kanter J
    J Pain Palliat Care Pharmacother; 2018 Mar; 32(1):20-26. PubMed ID: 29791238
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Childrens' and adolescents' use of diaries for sickle cell pain.
    Maikler VE; Broome ME; Bailey P; Lea G
    J Soc Pediatr Nurs; 2001; 6(4):161-9. PubMed ID: 11777329
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pain in children and adolescents with sickle cell disease: a descriptive study.
    Walco GA; Dampier CD
    J Pediatr Psychol; 1990 Oct; 15(5):643-58. PubMed ID: 2283573
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Do children with sickle cell disease receive disparate care for pain in the emergency department?
    Zempsky WT; Loiselle KA; McKay K; Lee BH; Hagstrom JN; Schechter NL
    J Emerg Med; 2010 Nov; 39(5):691-5. PubMed ID: 19703740
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Home care of vaso-occlusive crisis in sickle cell disease in Togo].
    Gbadoé AD; Atakouma DY; Akoli A; Assimadi JK
    Arch Pediatr; 1999 Sep; 6(9):958-61. PubMed ID: 10519029
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical Impact of Warmed Intravenous Saline in Sickle Cell Patients With Vasoocclusive Episodes.
    Quarrie RP; Stoner MJ; Choueiki JM; Bonsu BK; Cohen DM
    Pediatr Emerg Care; 2020 May; 36(5):229-235. PubMed ID: 32040047
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improving the Management of Vaso-Occlusive Episodes in the Pediatric Emergency Department.
    Kavanagh PL; Sprinz PG; Wolfgang TL; Killius K; Champigny M; Sobota A; Dorfman D; Barry K; Miner R; Moses JM
    Pediatrics; 2015 Oct; 136(4):e1016-25. PubMed ID: 26391933
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of vaso-occlusive pain in children with sickle cell disease.
    Jacob E; Miaskowski C; Savedra M; Beyer JE; Treadwell M; Styles L
    J Pediatr Hematol Oncol; 2003 Apr; 25(4):307-11. PubMed ID: 12679645
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The management of pain in sickle cell disease.
    Shapiro BS
    Pediatr Clin North Am; 1989 Aug; 36(4):1029-45. PubMed ID: 2666928
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Daily assessment of pain in adults with sickle cell disease.
    Smith WR; Penberthy LT; Bovbjerg VE; McClish DK; Roberts JD; Dahman B; Aisiku IP; Levenson JL; Roseff SD
    Ann Intern Med; 2008 Jan; 148(2):94-101. PubMed ID: 18195334
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characteristics of pain managed at home in children and adolescents with sickle cell disease by using diary self-reports.
    Dampier C; Ely B; Brodecki D; O'Neal P
    J Pain; 2002 Dec; 3(6):461-70. PubMed ID: 14622732
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost-effectiveness of adenotonsillectomy in reducing obstructive sleep apnea, cerebrovascular ischemia, vaso-occlusive pain, and ACS episodes in pediatric sickle cell disease.
    Tripathi A; Jerrell JM; Stallworth JR
    Ann Hematol; 2011 Feb; 90(2):145-50. PubMed ID: 20714723
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of ketorolac in pediatric sickle cell vaso-occlusive pain crisis.
    Hardwick WE; Givens TG; Monroe KW; King WD; Lawley D
    Pediatr Emerg Care; 1999 Jun; 15(3):179-82. PubMed ID: 10389953
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of a clinical pathway to improve the acute management of vaso-occlusive crisis pain in pediatric sickle cell disease.
    Ender KL; Krajewski JA; Babineau J; Tresgallo M; Schechter W; Saroyan JM; Kharbanda A
    Pediatr Blood Cancer; 2014 Apr; 61(4):693-6. PubMed ID: 24249617
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence-Based Practice Standard Care for Acute Pain Management in Adults With Sickle Cell Disease in an Urgent Care Center.
    Kim S; Brathwaite R; Kim O
    Qual Manag Health Care; 2017; 26(2):108-115. PubMed ID: 28375958
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Responsiveness of PROMIS® Pediatric Measures to Hospitalizations for Sickle Pain and Subsequent Recovery.
    Dampier C; Jaeger B; Gross HE; Barry V; Edwards L; Lui Y; DeWalt DA; Reeve BB
    Pediatr Blood Cancer; 2016 Jun; 63(6):1038-45. PubMed ID: 26853841
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of Clinical and Laboratory Parameters Associated with the Development of Acute Chest Syndrome during Vaso-Occlusive Episodes in Children with Sickle Cell Disease: A Preliminary Step before Assessing Specific and Early Treatment Strategies.
    Madhi F; Kamdem A; Jung C; Carlier-Gonod A; Biscardi S; Busca J; Arnaud C; Hau I; Narbey D; Epaud R; Pondarre C
    J Clin Med; 2019 Nov; 8(11):. PubMed ID: 31683997
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patient characteristics affect the response to ketamine and opioids during the treatment of vaso-occlusive episode-related pain in sickle cell disease.
    Nobrega R; Sheehy KA; Lippold C; Rice AL; Finkel JC; Quezado ZMN
    Pediatr Res; 2018 Feb; 83(2):445-454. PubMed ID: 28902183
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Vaso-occlusive pain crises in children with sickle cell anemia].
    Fournier-Charrière E
    Soins Pediatr Pueric; 2007 Feb; (234):21-6. PubMed ID: 17338413
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.